105 related articles for article (PubMed ID: 10591151)
1. Effects of adenosine A(2A) receptor stimulation in vivo on dopamine D3 receptor agonist binding in the rat brain.
Hillefors M; Hedlund PB; von Euler G
Biochem Pharmacol; 1999 Dec; 58(12):1961-4. PubMed ID: 10591151
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
3. Prominent binding of the dopamine D3 agonist [3H]PD 128907 in the caudate-putamen of the adult rat.
Hillefors M; von Euler M; Hedlund PB; von Euler G
Brain Res; 1999 Mar; 822(1-2):126-31. PubMed ID: 10082890
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D3 agonists disrupt social behavior in rats.
Kagaya T; Yonaga M; Furuya Y; Hashimoto T; Kuroki J; Nishizawa Y
Brain Res; 1996 May; 721(1-2):229-32. PubMed ID: 8793104
[TBL] [Abstract][Full Text] [Related]
6. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907.
Witkin J; Gasior M; Acri J; Beekman M; Thurkauf A; Yuan J; DeBoer P; Wikström H; Dijkstra D
Eur J Pharmacol; 1998 Apr; 347(2-3):R1-3. PubMed ID: 9741997
[TBL] [Abstract][Full Text] [Related]
8. Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907].
Witkin JM; Dijkstra D; Levant B; Akunne HC; Zapata A; Peters S; Shannon HE; Gasior M
J Pharmacol Exp Ther; 2004 Mar; 308(3):957-64. PubMed ID: 14711932
[TBL] [Abstract][Full Text] [Related]
9. Effects of CGS 21680 in vivo on dopamine D2 agonist binding in the rat brain.
Hillefors-Berglund M; Hedlund PB; von Euler G
Brain Res; 1995 Aug; 690(1):34-40. PubMed ID: 7496804
[TBL] [Abstract][Full Text] [Related]
10. The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptors.
Witkin JM; Levant B; Zapata A; Kaminski R; Gasior M
J Pharmacol Exp Ther; 2008 Sep; 326(3):930-8. PubMed ID: 18566292
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.
Hall H; Halldin C; Dijkstra D; Wikström H; Wise LD; Pugsley TA; Sokoloff P; Pauli S; Farde L; Sedvall G
Psychopharmacology (Berl); 1996 Dec; 128(3):240-7. PubMed ID: 8972543
[TBL] [Abstract][Full Text] [Related]
12. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
[TBL] [Abstract][Full Text] [Related]
13. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors.
Johansson B; Georgiev V; Fredholm BB
Neuroscience; 1997 Oct; 80(4):1187-207. PubMed ID: 9284070
[TBL] [Abstract][Full Text] [Related]
14. The D2/D3 agonist PD128907 (R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) inhibits stimulated pyloric relaxation and spontaneous gastric emptying.
Kashyap P; Micci MA; Pasricha S; Pasricha PJ
Dig Dis Sci; 2009 Jan; 54(1):57-62. PubMed ID: 18600456
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
Acquas E; Di Chiara G
Eur J Pharmacol; 1999 Oct; 383(2):121-7. PubMed ID: 10585525
[TBL] [Abstract][Full Text] [Related]
16. Ontogeny of the motor inhibitory role of dopamine D(3) receptor subtype in rats.
Heijtz RD; Ogren SO; Fuxe K
Eur J Pharmacol; 2000 Mar; 392(1-2):35-9. PubMed ID: 10748270
[TBL] [Abstract][Full Text] [Related]
17. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.
Koeltzow TE; Xu M; Cooper DC; Hu XT; Tonegawa S; Wolf ME; White FJ
J Neurosci; 1998 Mar; 18(6):2231-8. PubMed ID: 9482807
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptors play a role in the (-)-apomorphine-like discriminative stimulus effects of (+)-PD 128907.
Kleven MS; Koek W
Eur J Pharmacol; 1997 Feb; 321(1):1-4. PubMed ID: 9083778
[TBL] [Abstract][Full Text] [Related]
19. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
[TBL] [Abstract][Full Text] [Related]
20. Effects of the dopamine D3 antagonist PD 58491 and its interaction with the dopamine D3 agonist PD 128907 on brain dopamine synthesis in rat.
Whetzel SZ; Shih YH; Georgic LM; Akunne HC; Pugsley TA
J Neurochem; 1997 Dec; 69(6):2363-8. PubMed ID: 9375667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
